Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.
The dual role of neutrophils in cancer - ScienceDirect
Neutrophil Extracellular Traps May Augur Severe COVID-19
Dual targeting of LILRB and HLA-G in anti-cancer immunotherapy
ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit - ecancer
Positive opinion for orphan drug designation for avelumab in merkel cell carcinoma from ema committee for orphan medicinal products - ecancer
Two cancer research studies reveal essential role of neutrophils in immunotherapy - ecancer
Differential blood test: Uses, procedure, and results
Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis
ASCO GI: Less chemotherapy may have more benefit in rectal cancer - ecancer
Two Ludwig Cancer Research studies reveal essential role of neutrophils in immunotherapy
